Latest Pseudomonas Stories

MONMOUTH JUNCTION, N.J., June 10, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced positive data through six treatment cycles (72 weeks total duration) of its Phase 2 clinical trial program for ARIKACE® (liposomal amikacin for inhalation) in cystic fibrosis (CF) patients with Pseudomonas lung infections. The data were presented at the 34th European Cystic Fibrosis Conference in Hamburg, Germany, by Predrag Minic, M.D., Professor of...

As it turns out, humans aren't the only organisms that turn to caffeine for a pick-me-up. University of Iowa scientists have identified four different bacteria that actually can live on caffeine.One of them, known as Pseudomonas putida CBB5, was found in a flowerbed outside a UI research laboratory. The research team says the discovery -- and the new understanding of how the process works -- could in the future allow scientists to convert waste from leftover coffee, tea and even chocolate...

A new bacterium that uses caffeine for food has been discovered by a doctoral student at the University of Iowa. The bacterium uses newly discovered digestive enzymes to break down the caffeine, which allows it to live and grow."We have isolated a new caffeine-degrading bacterium, Pseudomonas putida CBB5, which breaks caffeine down into carbon dioxide and ammonia," says Ryan Summers, who presents his research today at the 111th General Meeting of the American Society for...

VIENNA, April 1, 2011 /PRNewswire/ -- Today Intercell AG (VSE: ICLL) announced that it has agreed with Novartis to advance Intercell's investigational Pseudomonas aeruginosa vaccine into a confirmatory clinical efficacy trial in ventilated ICU (Intensive Care Unit) patients. The planned double blind study is powered to show a clinically meaningful and statistically significant reduction in overall mortality between the vaccine and control group and envisages enrolling about 800 subjects....

Encapsulating antibiotics inside nanofibers, like a mummy inside a sarcophagus, gives them the amazing ability to destroy drug-resistant bacteria so completely that scientists described the remains as mere "ghosts," according to a report today at the the 241st National Meeting & Exposition of the American Chemical Society (ACS).Mohamed H. El-Newehy, Ph.D., leader of the nanofibers research team, said the new technology has potentially important applications in the on-going...

WASHINGTON, March 21, 2011 /PRNewswire-USNewswire/ -- Recent research aboard the space shuttle is giving scientists a better understanding of how infectious disease occurs in space and could someday improve astronaut health and provide novel treatments for people on Earth.(Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO) "With our space-based research efforts, including the International Space Station, we are not only continuing our human presence in space, but we are engaged...

Research published in the journal GENETICS suggests ways to increase the cost of antibiotic resistance and prolong the usefulness of antibioticsA team of scientists from the University of Oxford, U.K. have taken lessons from Adam Smith and Charles Darwin to devise a new strategy that could one day slow, possibly even prevent, the spread of drug-resistant bacteria. In a new research report published in the March 2011 issue of GENETICS (http://www.genetics.org), the scientists show that...

Agile Sciences' pharmaceutical compounds to be assessed for efficacy against bacterial isolates from cystic fibrosis patients. Raleigh, NC (PRWEB) March 11, 2011 Agile Sciences has been awarded a $75,000 grant from the Cystic Fibrosis Foundation which will facilitate testing of the company's lead pharmaceutical compounds toward bacterial isolates from cystic fibrosis patients. The company will collaborate with a leading cystic fibrosis expert and expects to complete the initial...

Plants are able to protect themselves from most bacteria, but some bacteria are able to breach their defences. In research to be published in Science on Friday, scientists have identified the genes used by some strains of the bacterium Pseudomonas to overwhelm defensive natural products produced by plants of the mustard family, or crucifers."Microbes only become pathogens when they find a way to infect a host and overwhelm the host defences," said lead author Dr Jun Fan from the...

RICHMOND, Va., March 3, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that the Pediatric Committee of the European Medicines Agency (EMA) has issued a positive opinion on the Company's Pediatric Investigation Plan (PIP) for ARIKACE(TM) (liposomal amikacin for inhalation), Insmed's Phase 3-ready compound for cystic fibrosis (CF) Pseudomonas and non-TB mycobacteria (NTM) lung infections. The PIP covers children from birth to 18 years of...